XML 48 R34.htm IDEA: XBRL DOCUMENT
v3.24.1.u1

Stock Options and Warrants (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2023
Stock Options and Warrants [Abstract] |
Schedule of Fair Values of Stock Options Granted | The fair values of stock options granted were estimated using the Black-Sholes option-pricing model with the following assumptions for the years ended December 31:
|  | 2023 |  |  | 2022 |
Risk-free interest rates |  |  | 3.70% - 3.97 | % |  |  | 1.38% - 2.73 | %
Expected life (in years) |  |  | 2.50 - 3.5 |  |  |  | 2.50 - 4.00 |
Expected volatility |  |  | 61 | % |  |  | 71.6% - 72.0 | %
Dividend yield |  |  | 0.00 | % |  |  | 0.00 | %
Weighted-average grant date fair value per share |  | $ | 3.46 |  |  | $ | 3.97 |
Schedule of Stock Options | A summary of the status of the Company’s stock options as of December 31, 2023 and 2022, and changes during the two years then ended are presented below.
|  |  |  |  | Wtd. Avg. |
|  |  |  |  | Exercise |
|  | Options |  |  | Price |
Balance, January 1, 2022 |  |  | 246,850 |  |  | $ | 12.54 |
Granted during the period |  |  | 62,000 |  |  |  | 8.40 |
Exercised during the period |  |  | - |  |  |  | - |
Terminated/Expired during the period |  |  | (5,800 | ) |  |  | 12.04 |
Balance, December 31, 2022 |  |  | 303,050 |  |  | $ | 11.70 |
Granted during the period |  |  | 189,620 |  |  |  | 3.46 |
Exercised during the period |  |  | - |  |  |  | - |
Terminated/Expired during the period |  |  | (30,800 | ) |  |  | 13.60 |
Balance, December 31, 2023 |  |  | 461,870 |  |  | $ | 8.34 |
Exercisable at December 31, 2023 |  |  | 397,539 |  |  | $ | 8.94 |
Schedule of Outstanding Stock Options | The following table summarizes information about outstanding stock options at December 31, 2023:
|  | Number |  |  |  |  | Wtd. Avg. |
Range of Exercise Price |  | Outstanding |  |  | Wtd.Avg, Life |  | Exercise Price |
$3.46 - $15.60 |  |  | 461,870 |  |  | 2.7 years |  | $ | 8.94 |
The following table summarizes information about exercisable stock options at December 31, 2022:
|  | Number |  |  |  |  | Wtd. Avg. |
Range of Exercise Price |  | Exercisable |  |  | Wtd.Avg, Life |  | Exercise Price |
$8.40 - $15.60 |  |  | 303,050 |  |  | 2.5 years |  | $ | 11.70 |
Schedule of Outstanding Warrants | The following tables summarize the Company’s outstanding warrants as of December 31, 2023 and changes during the two years then ended:
|  |  |  |  |  |  |  | Wtd. Avg. |
|  |  |  |  | Wtd. Avg. |  |  | Remaining |
|  |  |  |  | Exercise |  |  | Contractual |
|  | Warrants |  |  | Price |  |  | Life (years) |
Balance, January 1, 2022 |  |  | 150,722 |  |  | $ | 21.94 |  |  |  | 0.75 |
Granted during the period |  |  | - |  |  |  | - |  |  |  | - |
Terminated/Expired during the period |  |  | (122,722 | ) |  |  | 23.75 |  |  |  | - |
Balance, December 31, 2022 |  |  | 28,000 |  |  | $ | 14.00 |  |  |  | 0.75 |
Granted during the period |  |  | - |  |  |  | - |  |  |  | - |
Terminated/Expired during the period |  |  | (28,000 | ) |  | $ | 14.00 |  |  |  | - |
Balance, December 31, 2023 |  |  | - |  |  | $ | - |  |  |  | - |
Exercisable at December 31, 2023 |  |  | - |  |  | $ | - |  |  |  | - |

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for stock options and stock appreciation rights that were outstanding at the beginning and end of the year, exercisable at the end of the year, and the number of stock options and stock appreciation rights that were granted, exercised or converted, forfeited, and expired during the year. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (f)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-1 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration